← Leaderboards
Natalie A Sutkowski
Tufts University Boston
$698,687
Attributed
$698,687
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $157.3K · FY2005–11$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$698,687 · 3
By mechanism
K01$449,010 · 1
R03$221,250 · 1
P20$28,427 · 1
Top collaborators
No co-investigators on record.
Most similar at Tufts University Boston
Same institution · by research overlap
- Brigitte T. Huber$10,217,193
- David A Thorley-Lawson$13,752,380
- Peter A Bullock$4,067,693
- Julia Vera Halo$1,440,694
- Edward Geisinger$2,116,854
Others in their field
Top investigators on “B Lymphocyte”
- Barton F Haynes · Duke University$406,809,504
- Lawrence Corey · Fred Hutchinson Cancer Center$92,039,611
- Dan H. Barouch · Fred Hutchinson Cancer Center$89,832,818
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$83,920,398
- Dennis R. Burton · Scripps Research Institute$65,355,177
- Rafi Ahmed · Emory University$58,553,968
Research focus
B LymphocyteScid MouseLeukocyte Activation /TransformationOncogenic VirusSuperantigensT LymphocyteTransfection /Expression VectorViral CarcinogenesisAntigen Presenting CellTranscriptSpecimenTissuesTransfectionResponseProductionRetroviridaeLymphomaHead And Neck CancerAntiviral AntibodyGene ExpressionRecruitment ActivityEpstein Barr VirusGenetically Modified AnimalsClinical Research
Grant awards (7)
Placenta Growth Factor Inhibition in Head and Neck Cancer$110,625
R03 · FY2011 · DE · contact PI
Placenta Growth Factor Inhibition in Head and Neck Cancer$110,625
R03 · FY2010 · DE · contact PI
AN ENDOGENOUS SUPERANTIGEN IN HPV ASSOCIATED OROPHARYNGEAL CARCINOMA$28,427
P20 · FY2009 · RR · contact PI
Role of HERV-K18 Superantigen in EBV lymphomagenesis$157,275
K01 · FY2005 · CA
Role of HERV-K18 Superantigen in EBV lymphomagenesis$87,038
K01 · FY2004 · CA
Role of HERV-K18 Superantigen in EBV lymphomagenesis$70,237
K01 · FY2004 · CA
Role of HERV-K18 Superantigen in EBV lymphomagenesis$134,460
K01 · FY2003 · CA